Phase not reported / not applicableCompletedOBSERVATIONAL
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical Practice
ClinicalTrials.gov · NCT04878393 · Registry updated: 2025-09-24
- Condition / research focus
- Diabetes Mellitus, Type 2
- Sponsor
- Novo Nordisk A/S
- Countries with listed sites
- Japan
- Registry dates and results
- Start: 2021-04-30. Completion: 2023-02-09 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Oral semaglutide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Master Centre for Japan
Tokyo, Japan
Site recruitment: Not reported